Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Contezolid by MicuRx Pharmaceuticals for Diabetic Foot Infection (DFI): Likelihood of Approval
Contezolid is under clinical development by MicuRx Pharmaceuticals and currently in Phase III for Diabetic Foot Infection (DFI). According to...
Data Insights
Contezolid by MicuRx Pharmaceuticals for Diabetic Foot Infection (DFI): Likelihood of Approval
Contezolid is under clinical development by MicuRx Pharmaceuticals and currently in Phase III for Diabetic Foot Infection (DFI). According to...